The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
Abstract
BACKGROUND: Although radiofrequency catheter ablation (RFA) has evolved from an experimental procedure to an important treatment option for atrial fibrillation, the relative safety and efficacy of catheter ablation relative to that of antiarrhythmic drug (AAD) therapy has not been established. METHODS AND RESULTS: Two separate systematic reviews were conducted: one on RFA and the other on AAD to provide accurate and broadly representative estimates of the clinical efficacy and safety of both therapies in the treatment of atrial fibrillation. Electronic searches were conducted in EMBASE and MEDLINE from 1990 to 2007. For the RFA review, all study designs were accepted. For the AAD review, articles were limited to prospective studies on the following drugs of interest: amiodarone, dofetilide, sotalol, flecainide, and propafenone. Data were extracted by 1 reviewer, with a second reviewer performing independent confirmation of extracted data. Sixty-three RFA and 34 AAD studies were included in the reviews. Patients enrolled in RFA studies tended to be younger (mean age, 55 versus 62 years), had longer duration of atrial fibrillation (6.0 versus 3.1 years), and had failed a greater number of prior drug trials (2.6 versus 1.7). The single-procedure success rate of ablation off AAD therapy was 57% (95% CI, 50% to 64%), the multiple procedure success rate off AAD was 71% (95% CI, 65% to 77%), and the multiple procedure success rate on AAD or with unknown AAD usage was 77% (95% CI, 73% to 81%). In comparison, the success rate for AAD therapy was 52% (95% CI, 47% to 57%). A major complication of catheter ablation occurred in 4.9% of patients. Adverse events for AAD studies, although more common (30% versus 5%), were less severe. CONCLUSIONS: Studies of RFA for treatment of atrial fibrillation report higher efficacy rates than do studies of AAD therapy and a lower rate of complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Catheter ablation of AF is effective in restoring and maintaining sinus rhythm in patients with symptomatic paroxysmal, persistent, and probably long-standing persistent AF -in general as second-line treatment after failure of or intolerance to antiarrhythmic drug therapy.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In such patients, catheter ablation is more effective than antiarrhythmic drug therapy.185,586,713,[717][718][719][720]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In patients who experience symptomatic recurrences of AF despite antiarrhythmic drug therapy, all RCTs showed better sinus rhythm maintenance with catheter ablation than on antiarrhythmic drugs.586,713,727,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Most patients require more than one procedure to achieve symptom control.713,726,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“The rhythm outcome after catheter ablation of AF is difficult to predict in individual patients.173,227,713,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Sinus rhythm without severely symptomatic recurrences of AF is found in up to 70% of patients with paroxysmal AF, and around 50% in persistent AF. 713,728,735,1042”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“a meta-analysis of the available (weak) evidence suggests slightly better prevention of recurrent AF in patients treated with antiarrhythmic drugs after catheter ablation.713”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00006 · Cited by 2,184
Nademanee, K., McKenzie, J. P., Kosar, E. M., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., & Ngarmukos, T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.054 · Cited by 2,004
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Packer, D. L., & Skanes, A. C. (2005) · Circulation · doi:10.1161/01.cir.0000157153.30978.67 · Cited by 1,303
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,161
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142
Research works printed but not linked: 1
- 10.1161/circ.98.23.2574 · DOI
Cited by
Sorted by citations
Items 701–800 of 847
Paroxysmal atrial fibrillation
Haldar, S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199695546.003.0142 · Cited by 1
Who benefit most from catheter ablation of persistent atrial fibrillation?
Komatsu, Y., & Aonuma, K. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.01.12 · Cited by 1
New Ablation Technology Keeps Getting Cooler
Beer, D. A., & Berger, R. D. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.06.013 · Cited by 1
Heart Rhythm Interventions — Devil in the Details
Andrade, J. G. (2025) · New England Journal of Medicine · doi:10.1056/nejme2503817 · Cited by 1
Протасов, М. Е., Batalov, R. E., Хлынин, М. С., Анатольевна, П. Е., Валерьевна, К. И., & Popov, S. V. (2014) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2014-29-4-3-11
Atrial Fibrillation and Heart Failure in the Aging Population
Kazemian, P., & Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_5
Mapping Strategies in Failed and Redo Ablation of Atrial Arrhythmias
Wilton, S. B., Miyazaki, S., & Haı̈ssaguerre, M. (2012) · doi:10.1002/9781118481585.ch36
Impact of catheter ablation of atrial fibrillation on the left atrium
Hof, I. E. (2012) · Utrecht University Repository (Utrecht University)
Catheter Ablation of Atrial Fibrillation
Haegeli, L., Einthoven, W., Lewis, T., & Einthoven, W. (2013)
Short‐ and Long‐Term Efficacy of Catheter Ablation Procedures for Atrial fibrillation
Calkins, H. G., Bertaglia, E., Berruezo, A., Bonso, A., Kalman, J. M., MANSOUR, M. C., & Verma, A. (2011) · doi:10.1002/9781119963868.ch8
Clinical Trials on Atrial Fibrillation/Future Perspectives
Camm, A. J., Blomström‐Lundqvist, C., Dorian, P., Hohnloser, S. H., Morillo, C. A., Santangeli, P., Gelder, I. C. V., Wißner, E., & Kirchhof, P. F. (2011) · Wiley eBooks · doi:10.1002/9781119963868.ch10
Katheterablation bei Vorhofflimmern
Drewitz, I., Rostock, T., Hoffmann, B. A., Steven, D., Meinertz, T., & Willems, S. (2010) · Der Kardiologe · doi:10.1007/s12181-010-0264-4
Endpoints of Catheter Ablation for Atrial Fibrillation
Haı̈ssaguerre, M., Barrett, C. D., Biase, L. D., Ernst, S., Gaïta, F., Sánchez, J., Sanders, P., SCHILLING, R. J., & Willems, S. (2011) · doi:10.1002/9781119963868.ch4
Tóth, Z., Nagy-Baló, E., Kertész, A., Clemens, M., Herczku, C., Ţînţ, D., Kun, C., Edes, I. F., & Csanádi, Z. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28798
Kumar, S., Walters, T. E., Halloran, K., Morton, J. B., Hepworth, G., Wong, C. X. J., Kistler, P. M., Sanders, P., & Kalman, J. M. (2014) · Redalyc (Universidad Autónoma del Estado de México)
A shock in time saves ablation?
Siu, C., Tse, H., & Lau, C. (2010) · EP Europace · doi:10.1093/europace/euq454
“9% patients.(2) However, persistent AF promotes electrical and structural remodelling in the atria, which in turn create arrhythmogenic substrates facilitating AF maintenance as well as its recurrence.”
BackgroundQuel traitement anti-arythmique pour la fibrillation atriale paroxystique ?
Extramiana, F., MESSALI, A., Moubarak, G., & Leenhardt, A. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2010.02.043
Factores predictores de recurrencia post ablación de fibrilación auricular
Moreno, M., Oyarzún, R., Piedra, C., Orellana, M., & Marianella, S. R. (2012) · Revista chilena de cardiología · doi:10.4067/s0718-85602012000100004
Vorhofflimmern – Medikamentöse Therapie bei Rhythmus- oder Frequenzkontrolle
Müller-Burri, S.-A. (2014) · Therapeutische Umschau · doi:10.1024/0040-5930/a000485
Management of patients with atrial fibrillation at high risk of stroke: current treatment options
Edwards, D. (2012) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s16754
“It is more effective than medication at maintaining sinus rhythm, 26 and is associated with lower rates of stroke when registries of patients who have experienced ablation are compared with equivalent cohorts of patients who have not been ablated.”
Ranolazina: ¿tratamiento potencial de las arritmias?
Guasch, E., & Mont, L. (2010) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(10)70016-9
Kudenchuk, P. J. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1181-y
“Catheter ablation generally achieves better success than antiarrhythmic agents in maintaining sinus rhythm that can approach up to 90 % at 1 year follow-up [32–34], albeit less so among patients with persistent as compared with paroxysmal AF [35].”
BackgroundAblation of atrial fibrillation: pain relief by visualisation
Nørgaard, M. W., Pedersen, P. U., & Bjerrum, M. B. (2015) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2015.10.4.201
Should Catheter Ablation Be Indicated Only for Symptom-Relief of AF?
Iesaka, Y. (2011) · Journal of Arrhythmia · doi:10.1016/s1880-4276(11)80041-4
Digital resolution enhancement of intracardiac excitation maps during atrial fibrillation
Palmer, K. B., Thompson, N. C., Spector, P., Kalifa, J., & Bates, J. H. T. (2014) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-014-9597-z
“success rates, even though multiple procedures are often required [1].”
BackgroundAddressing the Controversy of Rate Versus Rhythm Control in Atrial Fibrillation
Contractor, T. A., Levin, V., Desai, R. V., & Marchlinski, F. E. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2701
Rate versus rhythm control in persistent atrial fibrillation
Moss, A. (2014) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2014.9.10.489
Remote Monitoring for Atrial Fibrillation
Man, J. P., Kapa, S., & Dixit, S. (2013) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.05.008
Catheter Ablation of Atrial Fibrillation in Octogenarians: The Right “Medicine?”
KIM, M. H. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02318.x
Follow-up nach Katheterablation von Vorhofflimmern
Klingenheben, T., Bänsch, D., Butter, C., Doll, N., Geller, J. C., Israel, C. W., Lewalter, T., Piorkowski, C., Posur, W., Rybak, K., et al. (2011) · Der Kardiologe · doi:10.1007/s12181-011-0327-1
Biase, L. D., Santangeli, P., Burkhardt, J. D., & Natale, A. (2013) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.11.003
Does omega-3 fatty acid supplementation prevent atrial fibrillation, and if so, which type?
Kirchhof, P. F. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2010.12.045
La ablación en la fibrilación auricular
Villuendas, R., & Alcalde, Ó. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.04.018
Cardiac Arrhythmia 2 Catheter ablation of atrial arrhythmias: state of the art
Lee, G., & Kalman, J. M. (2012)
Review Article Cryoballoon Ablation for Atrial Fibrillation
Andrade, J. G., Dubuc, M., Guerra, P. G., Macle, L., Roy, D., Talajic, M. R., Thibault, B., Khairy, P., & Montreal, E. (2012)
Ablation of paroxysmal atrial fibrillation in 2015: radiofrequency or cryoenergy?
Sousa, P. A., Bovéda, S., Combes, N., Combes, S., & Albenque, J. (2015) · Interventional Cardiology · doi:10.2217/ica.15.14
Macle, L., Khairy, P., Verma, A., Weerasooriya, R., Willems, S., Arentz, T., NOVAK, P. G., Veenhuyzen, G. D., Scavée, C., Skanes, A. C., et al. (2012)
Impact of population density of left atrial remodeling in patients with atrial fibrillation
Au, A. (2016) · J. Willard Marriott Library · doi:10.26053/0h-m3eg-0e00
UPMCHEART AND VASCULAR GRAND ROUNDS
Tein, C. A., Bazaz, R. R., & JaIN, K. (2014)
(2015) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2015.03.00097
Balloon Cryoablation for Paroxysmal Atrial Fibrillation. Initial Experience
Gonzalez, J., Galizio, N. O., Palazzo, A. A., Robles, F., Carnero, G. A., & Mysuta, M. A. (2015) · doi:10.7775/rac.v83.i5.6234
Haddad, M. E. (2014) · Ghent University Academic Bibliography (Ghent University)
Capítulo 6. Utilidad del mapeo tridimensional en la ablación de la fibrilación auricular paroxística
Negrete, A., & Gila, E. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.03.009
Quantitative assessment of synchronization during atrial fibrillation based on a novel index
Zhang, L., Yang, C., & Nie, Z. (2014) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2014.6943761
Prise en charge de la fibrillation auriculaire en 2011 Management of atrial fibrillation in 2011
Catez, E., Sina, B., Peperstraete, B., Ngoc, E. T., Castro, J. V. D. M., Morissens, M., Flores, G., Strachinaru, M., & Verbeet, T. W. (2011)
Kalil, C., Bartholomay, E., Borges, A. P., Gazzoni, G. F., de Lima, E., Etchepare, R., Moraes, R. M., Süssenbach, C. P., de Andrade, K., & Kalil, R. A. K. (2013)
Muligo, A. (2012)
[Studies on the energy for sperm motility (author's transl)].
Imamura, K. (1975) · PubMed
Kowalski, O., Zembala, M. O., Buchta, P., Filipiak, K. J., Sokal, A., Foremny, J., Boidol, J., Poloński, L., Kalarus, Z. F., & Zembala, M. (2010) · PubMed
Controversy: Differing energy sources/use of cryo‐energy
Kojodjojo, P., & Davies, D. W. (2015) · doi:10.1002/9781118658369.ch12b
Long‐standing persistent atrial fibrillation ablation
Biase, L. D., Santangeli, P., Perini, A. P., Santoro, F., Bai, R., Sánchez, J., Horton, R., BURKHARDT, J. D., & Natale, A. (2015) · doi:10.1002/9781118658369.ch22
Invasive management of atrial fibrillation
Vlachos, K. G., Letsas, Κ. P., & Efremidis, M. (2016) · Continuing Cardiology Education · doi:10.1002/cce2.35
“In comparison, the success rate for antiarrhythmic drug therapy was 52% [5].”
BackgroundVassilikos, V. P. (2016) · Continuing Cardiology Education · doi:10.1002/cce2.30
“5% incidence of complications, have been shown to be superior to drug treatment, regarding long-term success and quality of life improvement [5].”
Backgroundde Almeida, T. P. (2016) · Figshare
Ablación de fibrilación auricular mediante energía de radiofrecuencia
Guerrero, D. A. R., Montenegro-Aldana, J. D. J., Sáenz-Morales, L. C., & Garcia, F. C. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.021
de Oliveira, F. G., Pinto, I. M. F., Moreira, D. A. R., Miyake, D. A., Valdigem, B. P., & Senra, T. (2015) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.5935/2318-8219.20160007
Investigation of the mechanisms mediating genetic associations with atrial fibrillation
Martin, R. I. R. (2015)
Catheter Ablation of Atrial Fibrillation to Maintain Sinus Rhythm.
Dewire, J., & Calkins, H. G. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.739
Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?
Conti, S., & Verma, A. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0537-3
“reported an increased cumulative complication rate for AAD treatment compared to that of catheter ablation [14].”
ResultLeon, D., & Antônio, M. (2015) · instname:Universidad del Rosario
Atrial Fibrillation : treatment, associated conditions and quantification of symptoms
Höglund, N. (2017) · DiVA at Umeå University (Umeå University)
OBSOLETE: Catheter Ablation for Atrial Fibrillation (Methods)
Andrade, J. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99784-8
Deshmukh, A. J., & Packer, D. L. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_12
Wałek, P., Sielski, J. K., Gorczyca−Michta, I., Starzyk, K., Bartkowiak, R., & Wożakowska−Kapłon, B. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0108
Pitvarfibrilláció abláció indikációi és strokeprevenció a 2016-os új ESC ajánlások tükrében
Nagy, K. V., Szegedi, N., & Gellér, L. (2017) · Cardiologia Hungarica · doi:10.26430/chungarica.2017.47.3.200
Kochhäuser, S., Dechering, D. G., Trought, K., Hache, P., Haig-Carter, T., Wulffhart, Z. A., Pantano, A. A., Tsang, B., Eckardt, L., & Verma, A. (2016)
Application of intracardiac echocardiography for cardiac arrithmia ablation
Николаевич, Б. А., & Bondar, V. Y. (2017) · Annaly aritmologii · doi:10.15275/annaritmol.2017.2.5
16th Atrial Fibrillation Symposium
Wasek, S. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.6.4.s1
Nakahara, S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.09.59
“However, failure is not uncommon and almost two-thirds or less of the patients are free of AF at the long-term follow up (7,8).”
BackgroundWhat is the Latest on Catheter Ablation of Atrial Fibrillation?
Andrade, J. G., Deyell, M. W., & Macle, L. (2018) · Canadian Journal of General Internal Medicine · doi:10.22374/cjgim.v13isp1.308
Pitvarfibrilláció abláció szerepe szívelégtelen betegek kezelésében: fókuszban a CASTLE-AF-vizsgálat
Szegedi, N., Németh, T., Liptai, C., Nagy, A. I., Zima, E., Molnár, L., Tahin, T., Széplaki, G., Merkely, B. P., & Gellér, L. (2018) · Cardiologia Hungarica · doi:10.26430/chungarica.2018.48.4.249
Magnetic Resonance Imaging as the Arbitrator of Optimal Lesion Delivery During Catheter Ablation
Markman, T. M., & Nazarian, S. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.08.020
“With improvement in technology to achieve irreversible tissue injury and modified ablation strategies for pulmonary vein isolation and targeting of non– pulmonary vein triggers and drivers, ablation efficacy continues to improve (1,2).”
BackgroundKumar, S., & Michaud, G. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00076-6
Prediction of Atrial Fibrillation Recurrence by Pulmonary Vein Electrogram Correlation
Cervigón, R., Moreno, J., Millet, J., & Castells, F. (2018) · Computing in cardiology · doi:10.22489/cinc.2018.365
“Catheter ablation is a procedure widely used for rhythm control in patients with AF [10].”
BackgroundKochergin, N. А., Ganyukov, V. I., Mamchur, S. E., & Trubnikova, O. A. (2019) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2018-7-4s-86-93
“Эти данные подтверждает мета-анализ исследований, выполненных преимущественно на больных с пароксизмальной ФП [13].”
Ablation of Persistent and Long-Standing Persistent Atrial Fibrillation
Montgomery, J. A., & Michaud, G. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52992-1.00019-3
Grossman, L., Katz, M., Beinart, R., & Nof, E. (2019) · Clinical Cardiology · doi:10.1002/clc.23193
“This corresponds to previous data.(13) In previous study, a large LAD was found to be a predictor of AF occurrence.”
ResultZemlyanskaya, O. A., & Станиславовна, К. Е. (2019) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2019-1-62-71
“Убедительные доказательства небезопасности «терапии моста» были получены в рандомизированном двой ном слепом плацебо-контролируемом исследовании BRIDGE (Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery) [9].”
Do We Need Heart Teams for Complex Cardiac Arrhythmias? A Cardiologist’s Perspective
Ainslie, M., Reed, J. L., Lewis, K. B., & Birnie, D. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-19124-5_5
Nurse-directed Preventative Management of Atrial Fibrillation: Is it Feasible?
Huntsinger, M., & Doshi, R. N. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100904
Spatial Cross-Correlation to Determine Atrial Fibrillation Recurrence After Ablation
Cervigón, R., Pérez‐Villacastín, J., & Moreno, J. (2019) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-31635-8_3
Kaneshiro, T., Hijioka, N., Matsumoto, Y., Nodera, M., Yamada, S., Kamioka, M., & Takeishi, Y. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00659-z
“Identification of the pulmonary vein (PV) as a trigger for atrial fibrillation (AF) has made PV isolation (PVI) a widely accepted method for catheter ablation of AF, especially in patients with paroxysmal AF [1, 2].”
BackgroundProtocolo diagnóstico y terapéutico de la fibrilación auricular en Urgencias
Bertelli-García, G., Zafra-Sánchez, J., & de Teresa–Galván, E. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.11.008
Development of a Micro-thermal Sensor Based on 3-omega Technique for Dynamic Freezing Applications
Natesan, H. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Bockeria, L. A., Шалов, Р. З., Филатов, А. Г., Goryachev, V. A., & Сабиров, Ш. Н. (2019) · Annaly aritmologii · doi:10.15275/annaritmol.2019.4.1
Indications For AF Ablation: Before Or After The Failure Of Antiarrhythmic Drug Therapy?
Kimata, A., Ito, Y., & Yoshida, K. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1134
Catheter ablation of atrial fibrillation in Poland: promising results of a national survey
Cappato, R., & Ali, H. (2020) · Kardiologia Polska · doi:10.33963/kp.15610
Riddle, M., McCallum, R. W., Ojha, C. P., Paul, T. K., Gupta, V., Baran, D. A., Prakash, B. V., Misra, A., Mares, A. C., Abedin, M., et al. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001500
Guias de ablacion de arritmias cardiacas de la Federacion Argentina de Cardiologia
Keegan, R., Aguinaga, L., Secchi, J., Pozzer, D. L., Valentino, M., Femenía, F., Río, A. D., Feo, M. D., Bravo, A., & Martellotto, A. (2012)
Kochhäuser, S., & Riesinger, L. M. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1479-2528
“[7] Calkins H, Reynolds MR, Spector P et al.”
BackgroundAbe, I., Takahashi, N., Mukai, Y., Kimura, T., Yamaguchi, K., Takita, A., Origasa, H., Okumura, K., & on behalf of the KYU-RABLE Investigators (2021) · Thrombosis Journal · doi:10.1186/s12959-021-00305-7
“Among AF treatments, catheter ablation (CA) has been developed in the past decades, and there is increasing evidence on its efficacy and safety versus antiarrhythmic drugs [2, 3].”
BackgroundKatritsis, D. G., & Morady, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-79338-4.00022-4
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch10
Spector, P. (2019) · doi:10.1002/9781119524632.refs
(2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834294db
Bajpai, A., & Camm, A. J. (2012) · Wiley eBooks · doi:10.1002/9781118451786.ch5
Bajpai, A., & Camm, A. J. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch36
Metadata
- Authors
- Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I.
- Affiliations
- University of Vermont (US)
- Venue
- Circulation Arrhythmia and Electrophysiology
- Published
- 2009-08
- Volume
- 2
- Issue
- 4
- Pages
- 349-361
- ISSN
- 1941-3084 (ISSN-L)
- 1941-3149
- OpenAlex
- W2020741490
- Cited by
- 847
- References
- 128
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 42 · 2023: 33 · 2022: 38 · 2021: 48 · 2020: 35 · 2019: 37 · 2018: 43 · 2017: 54 · 2016: 62 · 2015: 63 · 2014: 72 · 2013: 69 · 2012: 74
- FWCI
- 43.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Arrhythmia and Electrophysiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, radiofrequency catheter ablation, antiarrhythmic drugs, amiodarone, dofetilide, sotalol, flecainide, propafenone, treatment efficacy, procedural complications, ablation success rate
- MeSH terms
- Anti-Arrhythmia Agents, Atrial Fibrillation, Humans, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
